113 related articles for article (PubMed ID: 24561054)
1. Primary tumor volume should be included in the TNM staging system of nasopharyngeal carcinoma.
Liu D; Long G; Mei Q; Hu G
Med Hypotheses; 2014 Apr; 82(4):486-7. PubMed ID: 24561054
[TBL] [Abstract][Full Text] [Related]
2. Primary tumor volume of nasopharyngeal carcinoma: significance for survival.
Lee CC; Ho HC; Lee MS; Hsiao SH; Hwang JH; Hung SK; Chou P
Auris Nasus Larynx; 2008 Sep; 35(3):376-80. PubMed ID: 18249078
[TBL] [Abstract][Full Text] [Related]
3. Significance of primary tumor volume and T-stage on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.
Chen C; Fei Z; Pan J; Bai P; Chen L
Jpn J Clin Oncol; 2011 Apr; 41(4):537-42. PubMed ID: 21242183
[TBL] [Abstract][Full Text] [Related]
4. [Clinical staging of nasopharyngeal carcinoma based on MRI: suggestions for improving the Chinese '92 staging system].
Mao YP; Hong MH; Sun Y; Liang SB; Li L; Liu LZ; Tang LL; Cao SM; Lin AH; Lu TX; Liu MZ; Ma J
Ai Zheng; 2007 Oct; 26(10):1099-106. PubMed ID: 17927881
[TBL] [Abstract][Full Text] [Related]
5. A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Poon I; Xia P; Weinberg V; Sultanem K; Akazawa C; Akazawa P; Verhey L; Quivey JM; Lee N
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1625-33. PubMed ID: 18035216
[TBL] [Abstract][Full Text] [Related]
6. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?
Lai SZ; Li WF; Chen L; Luo W; Chen YY; Liu LZ; Sun Y; Lin AH; Liu MZ; Ma J
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):661-8. PubMed ID: 20643517
[TBL] [Abstract][Full Text] [Related]
7. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.
Lin S; Pan J; Han L; Zhang X; Liao X; Lu JJ
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1071-8. PubMed ID: 19362784
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
9. Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.
Li WF; Sun Y; Mao YP; Chen L; Chen YY; Chen M; Liu LZ; Lin AH; Li L; Ma J
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):249-56. PubMed ID: 23200171
[TBL] [Abstract][Full Text] [Related]
10. Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome.
Lee CC; Huang TT; Lee MS; Hsiao SH; Lin HY; Su YC; Hsu FC; Hung SK
Radiat Oncol; 2010 Mar; 5():20. PubMed ID: 20222940
[TBL] [Abstract][Full Text] [Related]
11. Correlation between nasopharyngeal carcinoma tumor volume and the 2002 International Union Against Cancer tumor classification system.
Wu Z; Gu MF; Zeng RF; Su Y; Huang SM
Radiat Oncol; 2013 Apr; 8():87. PubMed ID: 23578324
[TBL] [Abstract][Full Text] [Related]
12. Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume.
Chen MK; Chen TH; Liu JP; Chang CC; Chie WC
Cancer; 2004 May; 100(10):2160-6. PubMed ID: 15139059
[TBL] [Abstract][Full Text] [Related]
13. Tissue polypeptide specific antigen (TPS) as a tumor marker in nasopharyngeal carcinoma.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(6C):4661-3. PubMed ID: 11205197
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of subclassification using MRI in the t4 classification nasopharyngeal carcinoma intensity-modulated radiotherapy treatment.
Chen L; Liu LZ; Chen M; Li WF; Yin WJ; Lin AH; Sun Y; Li L; Ma J
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):196-202. PubMed ID: 22300569
[TBL] [Abstract][Full Text] [Related]
16. Impact of primary tumor volume and location on the prognosis of patients with locally recurrent nasopharyngeal carcinoma.
Tian YM; Xiao WW; Bai L; Liu XW; Zhao C; Lu TX; Han F
Chin J Cancer; 2015 Jun; 34(6):247-53. PubMed ID: 26063113
[TBL] [Abstract][Full Text] [Related]
17. Correlation between MR imaging-derived nasopharyngeal carcinoma tumor volume and TNM system.
Chong VF; Zhou JY; Khoo JB; Chan KL; Huang J
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):72-6. PubMed ID: 16271442
[TBL] [Abstract][Full Text] [Related]
18. Beta-2-microglobulin (beta 2M) as a tumor marker in nasopharyngeal carcinoma.
Lee JK; Tsai SC; Hsieh JF; Ho YJ; Sun SS; Kao CH
Anticancer Res; 2000; 20(6C):4765-8. PubMed ID: 11205215
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of nasopharyngeal carcinoma staging by magnetic resonance imaging.
Lau KY; Kan WK; Sze WM; Lee AW; Yau TK; Tan LT; Chan PO
Australas Radiol; 2004 Mar; 48(1):14-6. PubMed ID: 15027914
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.
Shen C; Lu JJ; Gu Y; Zhu G; Hu C; He S
Laryngoscope; 2008 Jul; 118(7):1206-10. PubMed ID: 18418278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
